UK Trials Recruiting

The Adept PD Trial (nortriptyline)

This trial is recruiting 408 people across 30 centres across the UK. Funded by the NIHR with support from CPT, the trial lead is Professor Anette Schrag Royal Free London). Find out more about this trial.

The Bydureon (exenatide) Phase lll Trial

This clinical trial, supported by CPT and Van Andel Institute (VAI), is testing the effects of the diabetes drug Bydureon in people with Parkinson's. The trial is recruiting 200 participants in six centres in the UK.

The trial lead is Professor Tom Foltynie (UCL Queen Square, Neurology). Find out more about this trial.

The PD-STAT trial (simvastatin)

This trial is underway and recruitment has completed. Supported by CPT and J P Moulton Foundation, the results are expected in 2020. Find out more about Simvastatin and Parkinson's here.

The AIM-PD Study (ambroxol)

Supported by VAI and the John Black Foundation, the phase ll clinical trial of Ambroxol in Parkinson's has completed. The next stage of the programme will be recruiting soon and details will follow. Find out more about Ambroxol in Parkinson's here.

The FAIRPARK ll Trial (deferiprone)

Two phase ll trials addressing the safety and tolerability of Deferiprone in people with Parkinson’s has completed and the next phase will be recruiting soon. Find out more about Deferiprone in Parkinson's here.

The UP Study (UDCA)

This trial is now underway and recruitment is now complete. Supported by CPT and J P Moulton Foundation, the results are expected 2020/21 Find out more about the UDCA in Parkinson's study here.

Non-UK Trials Recruiting

The Lixisenatide Trial - France 

Another trial with the promising GLP-1 receptor agonist cohort and co-funded by CPT and VAI through the international Linked Clinical Trials initiative, this study will evaluate the effect of the diabetes drug lixisenatide versus placebo in Parkinson's. Find out more about this trial here.

The Liraglutide Trial - U.S.

A further GLP-1 agonist trial is taking place at the Cedars-Sinai Medical Center, Los Angeles, U.S. and was selected by the international Linked Clinical Trials committee. It is being co-funded by CPT and VAI. Find out more about this trial here.

Further Trials Recruiting

Although not funded by CPT, there are further trials that may be of interest. If you do not match the eligibility criteria for one of the trials above, the trials below might be more relevant to you and will be recruiting in 2020:

Chief PD is seeking to recruit over 600 participants

Trial Recruitment Websites

NIHR - Be Part of Research

The Hope List - Dr Kevin McFarthing